Clinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up

dc.contributor.authorYildiz B.S.
dc.contributor.authorGunduz R.
dc.contributor.authorOzgur S.
dc.contributor.authorCizgici A.Y.
dc.contributor.authorOzdemir I.H.
dc.date.accessioned2024-07-22T08:03:23Z
dc.date.available2024-07-22T08:03:23Z
dc.date.issued2023
dc.description.abstractCoronary artery perforation (CAP) is a potentially fatal complication of percutaneous coronary intervention (PCI) in acute coronary syndrome (ACS). This study aimed to investigate in-hospital, 1-year, and 3-year clinical outcomes of type III CAP during PCI in patients with ACS. The study retrospectively evaluated 118 patients with CAP and 43,226 case-control patients. Clinical, angiographic, and procedural characteristics, management, and outcomes were analyzed retrospectively at 1-year and 3-year follow-ups. The mean age of the patients was 66.5 ± 11.9 years (61.8% males). There was no significant difference in hospital mortality between the type III CAP and non-CAP groups. The all-cause mortality was 33.3% in the CAP group vs 1.8% in the non-CAP group at 1 year, and 28.3% in CAP group vs 6.9% in non-CAP group at 3 years (p =.001 for both comparisons). The procedural, clinical, and 1 and 3-year outcomes of type III CAP showed a relatively high risk of myocardial infarction, coronary artery bypass graft, cerebrovascular event, stent thrombosis, and major bleeding at the 1 and 3-year follow-ups. In addition, non-CAP ACS patients had better survival (log-rank: p <.001, 34.29 months 95% Confidence Interval [33.58–35.00]) than type III CAP ACS patients (29.53 months 95% Confidence Interval [27.28–31.78]) at the 3-year follow-up visit. © The Author(s) 2023.
dc.identifier.DOI-ID10.1177/00033197231200029
dc.identifier.issn00033197
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12265
dc.language.isoEnglish
dc.publisherSAGE Publications Inc.
dc.titleClinical Outcomes of Comparison Between Type III Coronary Artery Perforation (CAP) and non-CAP Acute Coronary Syndrome Patients During 3-Year Follow-up
dc.typeArticle

Files